Prakash Manoharan
Overview
Explore the profile of Prakash Manoharan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
803
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McDaid L, Datta A, Bonington S, Manoharan P, OConnor J, Hoskin P, et al.
J Med Imaging Radiat Sci
. 2025 Feb;
56(3):101863.
PMID: 39983316
Introduction/background: Healthy volunteer imaging is integral to optimising sequences for use in a treatment planning pathway to ensure they are fit for purpose. Although initial imaging may not be optimal...
2.
Ramzan A, Chander A, Westwood T, Elias M, Manoharan P
Front Nucl Med
. 2024 Nov;
4:1477467.
PMID: 39507633
Hibernomas are rare brown fat tumors that garnered attention in the literature with the increasing use of [F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography ([F] FDG PET/CT) for the staging workup...
3.
Khan S, Rushbrook S, Kendall T, Zen Y, Albazaz R, Manoharan P, et al.
Gut
. 2024 Aug;
74(3):504-505.
PMID: 39160057
No abstract available.
4.
Dubec M, Price J, Berks M, Gaffney J, Little R, Porta N, et al.
Clin Cancer Res
. 2024 Aug;
30(24):5620-5629.
PMID: 39142654
Purpose: Hypoxia mediates treatment resistance in solid tumors. We evaluated if oxygen-enhanced MRI-derived hypoxic volume (HVMRI) is repeatable and can detect radiotherapy-induced hypoxia modification in human papillomavirus-associated oropharyngeal head and...
5.
Rushbrook S, Kendall T, Zen Y, Albazaz R, Manoharan P, Pereira S, et al.
Gut
. 2023 Sep;
73(1):16-46.
PMID: 37770126
These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included a multidisciplinary team of experts...
6.
de Mestier L, Resche-Rigon M, Dromain C, Lamarca A, La Salvia A, de Baker L, et al.
J Neuroendocrinol
. 2023 Jun;
35(6):e13311.
PMID: 37345276
RECIST 1.1 criteria are commonly used with computed tomography (CT) to evaluate the efficacy of systemic treatments in patients with neuroendocrine tumors (NETs) and liver metastases (LMs), but their relevance...
7.
Kapacee Z, Allison J, Dawod M, Wang X, Frizziero M, Chakrabarty B, et al.
Curr Oncol
. 2022 Jul;
29(7):5110-5125.
PMID: 35877265
Background: Brain metastases (BMs) in patients with extra-pulmonary neuroendocrine neoplasms (EP-NENs) are rare, and limited clinical information is available. The aim of this study was to detail the clinicopathological features,...
8.
Kershaw L, Forker L, Roberts D, Sanderson B, Shenjere P, Wylie J, et al.
BJR Open
. 2022 Jun;
3(1):20200061.
PMID: 35707756
Objective: Soft tissue sarcoma (STS) is a rare malignancy with a 5 year overall survival rate of 55%. Neoadjuvant radiotherapy is commonly used in preparation for surgery, but methods to...
9.
Conway A, Morris G, Smith S, Vekeria M, Manoharan P, Mitchell C, et al.
Br J Cancer
. 2022 Apr;
127(3):531-540.
PMID: 35484217
Background: Many patients referred with a provisional diagnosis of cancer of unknown primary (pCUP) present with presumed metastatic disease to the liver. Due to the lack of definitive histological markers,...
10.
Cuthbertson D, Barriuso J, Lamarca A, Manoharan P, Westwood T, Jaffa M, et al.
Front Endocrinol (Lausanne)
. 2021 Jun;
12:654975.
PMID: 34163434
Objective: Pancreatic neuroendocrine tumours (panNETs) arise sporadically or as part of a genetic predisposition syndrome. CT/MRI, endoscopic ultrasonography and functional imaging using Octreoscan localise and stage disease. This study aimed...